{"id":"https://openalex.org/W2462950391","doi":null,"title":"CP-0127, a novel potent bradykinin antagonist, increases survival in rat and rabbit models of endotoxin shock.","display_name":"CP-0127, a novel potent bradykinin antagonist, increases survival in rat and rabbit models of endotoxin shock.","publication_year":1992,"publication_date":"1992-01-01","ids":{"openalex":"https://openalex.org/W2462950391","mag":"2462950391","pmid":"https://pubmed.ncbi.nlm.nih.gov/1462875"},"language":"en","primary_location":{"id":"pmid:1462875","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/1462875","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Agents and actions. Supplements","raw_type":"Journal Article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5108200487","display_name":"Eric T. Whalley","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"E T Whalley","raw_affiliation_strings":["Cortech, Inc., Denver, Colorado 80206"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cortech, Inc., Denver, Colorado 80206","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022819995","display_name":"Solomon Ja","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J A Solomon","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078478456","display_name":"Dennis Modafferi","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"D M Modafferi","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040839100","display_name":"Bonham Ka","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"K A Bonham","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5075795213","display_name":"John C. Cheronis","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J C Cheronis","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":2.8736,"has_fulltext":false,"cited_by_count":39,"citation_normalized_percentile":{"value":0.90957531,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":95},"biblio":{"volume":"38 ( Pt 3)","issue":null,"first_page":"413","last_page":"20"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11917","display_name":"Coagulation, Bradykinin, Polyphosphates, and Angioedema","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11917","display_name":"Coagulation, Bradykinin, Polyphosphates, and Angioedema","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10218","display_name":"Sepsis Diagnosis and Treatment","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2706","display_name":"Critical Care and Intensive Care Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10993","display_name":"Complement system in diseases","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/bradykinin-receptor-antagonists","display_name":"bradykinin receptor antagonists","score":0.9419999718666077},{"id":"https://openalex.org/keywords/endotoxic-shock","display_name":"endotoxic shock","score":0.8610000014305115},{"id":"https://openalex.org/keywords/kallikrein-kinin-system","display_name":"kallikrein-kinin system","score":0.9229999780654907},{"id":"https://openalex.org/keywords/lipopolysaccharide","display_name":"lipopolysaccharide","score":0.9309999942779541},{"id":"https://openalex.org/keywords/survival","display_name":"survival","score":0.765999972820282}],"concepts":[{"id":"https://openalex.org/C2779591629","wikidata":"https://www.wikidata.org/wiki/Q24745328","display_name":"Bradykinin","level":3,"score":0.9444055557250977},{"id":"https://openalex.org/C2776885963","wikidata":"https://www.wikidata.org/wiki/Q245204","display_name":"Antagonist","level":3,"score":0.7500777244567871},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.651305079460144},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6146413683891296},{"id":"https://openalex.org/C2776246183","wikidata":"https://www.wikidata.org/wiki/Q421924","display_name":"Kinin","level":4,"score":0.5732522010803223},{"id":"https://openalex.org/C2777397205","wikidata":"https://www.wikidata.org/wiki/Q275792","display_name":"Saline","level":2,"score":0.48650187253952026},{"id":"https://openalex.org/C2781300812","wikidata":"https://www.wikidata.org/wiki/Q178061","display_name":"Shock (circulatory)","level":2,"score":0.46810221672058105},{"id":"https://openalex.org/C153939273","wikidata":"https://www.wikidata.org/wiki/Q24721039","display_name":"Bradykinin receptor","level":4,"score":0.4549545347690582},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.4523131251335144},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.38949596881866455},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.35879260301589966},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.2120911180973053}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001794","descriptor_name":"Blood Pressure","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D001920","descriptor_name":"Bradykinin","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D001920","descriptor_name":"Bradykinin","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D004195","descriptor_name":"Disease Models, Animal","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004926","descriptor_name":"Escherichia coli","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010455","descriptor_name":"Peptides","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D010455","descriptor_name":"Peptides","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D011817","descriptor_name":"Rabbits","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012772","descriptor_name":"Shock, Septic","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D012772","descriptor_name":"Shock, Septic","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":false},{"descriptor_ui":"D017207","descriptor_name":"Rats, Sprague-Dawley","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:1462875","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/1462875","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Agents and actions. Supplements","raw_type":"Journal Article"},{"id":"mag:2462950391","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/1462875","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9537000060081482}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2397251924","https://openalex.org/W2285451443","https://openalex.org/W2465450808","https://openalex.org/W1971442453","https://openalex.org/W2274060007","https://openalex.org/W2041734703","https://openalex.org/W2418981508","https://openalex.org/W2042379517","https://openalex.org/W2044404166","https://openalex.org/W2416628831"],"abstract_inverted_index":{"The":[0,137],"bradykinin":[1,19,39,165],"antagonist":[2,166],"dimer":[3],"CP-0127":[4,81,120,169],"was":[5,40,75,114],"found":[6],"to":[7,18,38,73,90,103,126],"be":[8],"a":[9,29,59,84,98,109,145,164],"potent":[10],"and":[11,24,61,158],"selective":[12],"inhibitor":[13],"of":[14,45,112,139,155,163],"the":[15,21,35,43,46,71,149,160],"depressor":[16,36],"response":[17,37,72],"in":[20,66,105,116,128,152,174],"anaesthetized":[22,51],"rat":[23],"rabbit.":[25],"When":[26],"given":[27,82,132],"as":[28,83,168],"single":[30,85],"dose":[31,87],"s.c.":[32],"(3.6":[33,88],"mumol/kg),":[34],"blocked":[41],"for":[42,144,148,170],"duration":[44],"experiment":[47],"(4":[48],"hours).":[49],"In":[50,79],"control":[52,106,130],"rats,":[53],"LPS":[54,74,95,133],"from":[55],"E.":[56],"coli":[57],"produced":[58,97],"profound":[60],"immediate":[62],"hypotensive":[63],"response,":[64],"while":[65],"rats":[67,91],"infused":[68,118],"with":[69,119],"CP-0127,":[70],"almost":[76],"totally":[77],"reversed.":[78],"addition,":[80],"subcutaneous":[86],"mumol/kg)":[89],"1":[92],"hour":[93],"before":[94],"challenge":[96],"93%":[99],"survival":[100,110],"rate,":[101],"compared":[102,125],"14%":[104],"animals.":[107],"Finally,":[108],"rate":[111],"86%":[113],"achieved":[115],"rabbits":[117],"at":[121],"0.36":[122],"nmol/kg/min":[123],"i.v.,":[124],"45.5%":[127],"saline-infused":[129],"animals":[131],"(500":[134],"micrograms/kg":[135],"i.v.).":[136],"results":[138],"these":[140,153],"experiments":[141],"provide":[142],"evidence":[143],"significant":[146],"role":[147],"kallikrein-kinin":[150],"system":[151],"models":[154],"endotoxic":[156],"shock,":[157],"indicate":[159],"therapeutic":[161],"potential":[162],"such":[167],"treating":[171],"this":[172],"disorder":[173],"man.":[175]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":2},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-07-22T00:00:00"}